search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
THINK GLOBAL PEOPLE HEALTH & WELLBEING


“ PERHAPS FOR THE FIRST TIME IN A LONG TIME, HEALTH AND SAFETY HAS BECOME THE NUMBER ONE PRIORITY ALONGSIDE KEEPING THE BUSINESS AFLOAT”


and cons of the assignment against the risks, says Dr Kate O’Reilly, Medical Director Information & Analysis at International SOS. “Agility, accurate information and good communications are key to a sustainable and safe return to work and operations. “Hopefully most organisations


have, or are imminently reviewing, BCP (business continuity planning) and pandemic planning in respect of the current environment. These need to have an element of flexibility in order to respond to any changes and implement subsequent best practice advice and regulations.”


SUPPORTING A RANGE OF SCENARIOS Many large multinational companies have announced they will not return to office-based work until a vaccine is found. While employers believe remote working will be a “lasting switch”, bringing with it further health, wellbeing and productivity challenges and opportunities, two developments in vaccine and testing for Covid-19 could make more office-based working a reality sooner rather than later. A tie-up between the University


of Oxford and pharmaceutical firm AstraZeneca has announced breakthroughs in vaccine research, but no antidote to SARS-CoV-2 yet exists. However, could the newly announced rapid testing innovation, LamPORE, innovated by the Oxford University’s spin- off firm, Oxford Nanopore Technologies, change the game for employers, business travellers and the wider population? Adrian Hyzler, Chief Medical Officer of global healthcare, assistance and risk management solutions Healix International, which has updated its Covid-19 advisory, says the medium-term prospects are hopeful. “LAMP technology is not


new, but it has huge potential to change the landscape of testing for Covid-19,” says Mr Hyzler. “It offers affordable, point-of-care testing that can be carried out without specialised laboratory staff. The test takes less than an hour to get results and can be scaled up to analyse many thousands of tests a day from a portable desktop machine. The results are accurate and affordable.


31


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58